Literature DB >> 15147823

The effect of PEGT/PBT scaffold architecture on oxygen gradients in tissue engineered cartilaginous constructs.

J Malda1, T B F Woodfield, F van der Vloodt, F K Kooy, D E Martens, J Tramper, C A van Blitterswijk, J Riesle.   

Abstract

Repair of articular cartilage defects using tissue engineered constructs composed of a scaffold and cultured autologous cells holds promise for future treatments. However, nutrient limitation (e.g. oxygen) has been suggested as a cause of the onset of chondrogenesis solely within the peripheral boundaries of larger constructs. In the present study, oxygen gradients were evaluated by microelectrode measurements in two porous polyethylene glycol terephthalate/polybutylene terephthalate (PEGT/PBT) scaffold architectures, a compression-molded and particle-leached sponge (CM) and a 3D-deposited fiber (3DF) scaffold. During the first 14 days in vitro, gradients intensified, after which a gradual decrease of the gradients was observed in vitro. In vivo, however, gradients changed instantly and became less pronounced. Although similar gradients were observed regardless of scaffold type, significantly more cells were present in the center of 3DF constructs after 2 weeks of in vivo culture. Our results stress the importance of a rationally designed scaffold for tissue-engineering applications. Organized structures, such as the 3DF PEGT/PBT polymer scaffolds, offer possibilities for regulation of nutrient supply and, therefore, hold promise for clinical approaches for cartilage repair.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147823     DOI: 10.1016/j.biomaterials.2004.01.028

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  31 in total

1.  Travelling-wave behaviour in a multiphase model of a population of cells in an artificial scaffold.

Authors:  G Lemon; J R King
Journal:  J Math Biol       Date:  2007-05-12       Impact factor: 2.259

Review 2.  Strategies and applications for incorporating physical and chemical signal gradients in tissue engineering.

Authors:  Milind Singh; Cory Berkland; Michael S Detamore
Journal:  Tissue Eng Part B Rev       Date:  2008-12       Impact factor: 6.389

Review 3.  Progress of key strategies in development of electrospun scaffolds: bone tissue.

Authors:  Sumit Pramanik; Belinda Pingguan-Murphy; Noor Azuan Abu Osman
Journal:  Sci Technol Adv Mater       Date:  2012-08-08       Impact factor: 8.090

4.  Noninvasive imaging of nanoparticle-labeled transplant populations within polymer matrices for neural cell therapy.

Authors:  Jacqueline A Tickle; Harish Poptani; Arthur Taylor; Divya M Chari
Journal:  Nanomedicine (Lond)       Date:  2018-06       Impact factor: 5.307

5.  Mass transfer trends occurring in engineered ex vivo tissue scaffolds.

Authors:  Marc Moore; Malisa Sarntinoranont; Peter McFetridge
Journal:  J Biomed Mater Res A       Date:  2012-05-24       Impact factor: 4.396

6.  Biofabrication of osteochondral tissue equivalents by printing topologically defined, cell-laden hydrogel scaffolds.

Authors:  Natalja E Fedorovich; Wouter Schuurman; Hans M Wijnberg; Henk-Jan Prins; P René van Weeren; Jos Malda; Jacqueline Alblas; Wouter J A Dhert
Journal:  Tissue Eng Part C Methods       Date:  2011-10-04       Impact factor: 3.056

7.  A triphasic constrained mixture model of engineered tissue formation under in vitro dynamic mechanical conditioning.

Authors:  Joao S Soares; Michael S Sacks
Journal:  Biomech Model Mechanobiol       Date:  2015-06-09

Review 8.  TMJ Bioengineering: A review.

Authors:  Divya Mehrotra
Journal:  J Oral Biol Craniofac Res       Date:  2013-10-12

9.  Downregulation of metabolic activity increases cell survival under hypoxic conditions: potential applications for tissue engineering.

Authors:  Jaehyun Kim; Karl-Erik Andersson; John D Jackson; Sang Jin Lee; Anthony Atala; James J Yoo
Journal:  Tissue Eng Part A       Date:  2014-07-02       Impact factor: 3.845

Review 10.  3D tissue-engineered model of Ewing's sarcoma.

Authors:  Salah-Eddine Lamhamedi-Cherradi; Marco Santoro; Vandhana Ramammoorthy; Brian A Menegaz; Geoffrey Bartholomeusz; Lakesla R Iles; Hesham M Amin; J Andrew Livingston; Antonios G Mikos; Joseph A Ludwig
Journal:  Adv Drug Deliv Rev       Date:  2014-08-07       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.